The Richard Stravitz Foundation is highly focused on funding biomedical research into amyotrophic lateral sclerosis (ALS), providing large, research-specific grants to major academic medical centers and specialty research institutes. Its giving concentrates on translational and clinical ALS research programs rather than broad health or community services, with repeat multi-year support to leading hospitals and a willingness to fund prominent international research centers.
The Richard Stravitz Foundation’s recent giving is anchored by large, repeated support for ALS research at major medical centers. In 2025, it awarded $580,000 to Emory University Hospital in Atlanta and $500,000 to Massachusetts General Hospital in Boston, continuing a multi-year pattern of funding clinical and translational ALS work at institutions with established research programs. That pattern also appears in its support for specialty ALS centers and neurology research hubs, including the R Packard Center for ALS Research and UCL Queen Square Institute of Neurology. The foundation’s grants are directed to hospitals, universities, and research organizations rather than to individuals, and the listed grants show a strong concentration in biomedical research infrastructure. Several recipients appear across multiple years, suggesting ongoing relationships rather than isolated awards. Its recent portfolio also extends to ALS-specific nonprofits and related medical institutions, with grant purposes that commonly reference ALS research or general and capital purposes. Across the latest grants, the foundation is funding research capacity, clinical programs, and specialized institutes that work on amyotrophic lateral sclerosis.
Clinical ALS research is the clearest thread in the foundation’s recent grants. It gave $510,000 in 2024 and $360,000 in 2023 to Emory University Hospital for ALS Research, showing continued support for the same hospital-based program. At Massachusetts General Hospital, the foundation made ALS Research grants of $425,000 in 2024 and $225,000 in 2023. It also supported research infrastructure and specialist networks: $150,000 to the R Packard Center for ALS Research for General & Capital Purposes, unless noted, and $100,000 to the Northeast ALS Consortium for the same purpose. Beyond research hospitals, the foundation backed ALS-focused nonprofits and medical groups, including $75,000 to the ALS Association in 2025 and $50,000 to the Team Gleason Foundation in 2025.
Typical grant size sits in a mid-five-figure range: the 25th percentile is $24,500, the median is $37,500, and the 75th percentile is $56,500. The foundation also makes much larger research grants, especially to major hospitals. Several recipients appear in multiple years, including Emory University Hospital, Massachusetts General Hospital, University College London, University of Michigan, Barrow Neurological Foundation, ALS Association, and Team Gleason Foundation. The structure of the awards mixes ALS Research with General & Capital Purposes, unless noted, indicating support for both program work and infrastructure. The foundation does not fund individuals and does not make program-related investments.
$2.6M
$20.3M
$4.6M
$2.9M
Most grants fall between $25K and $57K, with a median of $38K.
25th Percentile
$25K
Median
$38K
75th Percentile
$57K
About 10% of grants go to recipients in NY.
Top 2 recipient countries by grant volume for Richard Stravitz Foundation.
| Rank | Country | Grants | Total | Share |
|---|---|---|---|---|
| 1 | United StatesDomestic | 70 | $6.5M | 95.9% |
| 2 | United Kingdom |
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Concentrated, large-dollar grants to a small number of repeat grantees focused on ALS research; funding is targeted to established institutions with demonstrated research capacity rather than many small or grassroots grants.
Notable grantees: Emory University Hospital, Massachusetts General Hospital, R. Packard Center for ALS Research, UCL Queen Square Institute of Neurology
The foundation gives nationally, but the largest share of grants goes to recipients in Virginia, which accounts for 23% of grants. Recent Virginia recipients include Virginia Beach, Norfolk, and Arlington. Outside the U.S., grants also reached London-based institutions in the UK, including UCL Queen Square Institute of Neurology and University College London. U.S. recipients are spread across major research and medical centers in cities such as Atlanta, Boston, Baltimore, Ann Arbor, New York, Phoenix, New Orleans, and San Diego.
Its recent grants are concentrated in ALS research, especially clinical and translational work at hospitals, universities, and specialist research centers. The data also shows support for research infrastructure and capital needs, alongside ALS-focused nonprofits and neurologic research institutions.
Recipients are medical schools, hospitals, research centers, and nonprofit organizations. Recent grants went to institutions such as Emory University Hospital, Massachusetts General Hospital, UCL Queen Square Institute of Neurology, the R Packard Center for ALS Research, and the ALS Association.
The typical grant size is $24,500 at the 25th percentile, $37,500 at the median, and $56,500 at the 75th percentile. Recent awards also include much larger six-figure grants to major ALS research programs.
No. Most grants went to U.S. recipients, but the grant list also includes three grants in the UK, including London-based neurological research institutions.
Yes. Several recipients appear across multiple years, including Emory University Hospital, Massachusetts General Hospital, University College London, University of Michigan, Barrow Neurological Foundation, ALS Association, and Team Gleason Foundation. That pattern suggests ongoing support rather than one-time awards.
2026
Source: IRS Form 990-PF, fiscal year 2026.
| 3 |
| $276K |
4.1% |
Recipient country reflects the grantee's headquarters per IRS 990-PF and Schedule F filings, not the program's implementation country.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| Emory University Hospital | Atlanta, GA | $1,325,000 | 2026 | ALS Research |
| Massachusetts General Hospital | Boston, MA | $500,000 | 2026 | ALS Research |
| John Hopkons University | Baltimore, MD | $150,000 | 2026 | General & Capital Purposes, unless noted |
| University of Michigan | Ann Arbor, MI | $100,000 | 2026 | ALS Research |
| Doctors Without Borders USA Inc | New York, NY | $95,000 | 2026 | General & Capital Purposes, unless noted |
| ALS Association | Arlington, MD | $75,000 | 2026 | ALS Research |
| ALS Therapy Development Institute | Watertown, MA | $70,000 | 2026 | General & Capital Purposes, unless noted |
| Team Gleason Foundation | New Orleans, LA | $60,000 | 2026 | General & Capital Purposes, unless noted |
| Hospital for Special Surgery | New York, NY | $50,000 | 2026 | General & Capital Purposes, unless noted |
| Cedar Sinai | Los Angeles, CA | $30,000 | 2026 | General & Capital Purposes, unless noted |
| Hope Loves Company | Pennington, NJ | $15,000 | 2026 | General & Capital Purposes, unless noted |
| Les Turner Foundation | Skokie, IL | $10,000 | 2026 | General & Capital Purposes, unless noted |
| MCV Foundation | Richmond, VA | $10,000 | 2026 | General & Capital Purposes, unless noted |
| Target ALS Foundation | New York, NY | $10,000 | 2026 | General & Capital Purposes, unless noted |
| Peter Cohen Foundation | Seattle, WA | $10,000 | 2026 | General & Capital Purposes, unless noted |
| ALS One | Whitman, MA | $10,000 | 2026 | General & Capital Purposes, unless noted |
| Hop On a Cure Foundation | Roswell, GA | $10,000 | 2026 | General & Capital Purposes, unless noted |
| Project ALS | Huntington, MD | $10,000 | 2026 | General & Capital Purposes, unless noted |
| Answer ALS | New Orleans, LA | $10,000 | 2026 | General & Capital Purposes, unless noted |
| ALS United New York | New York, NY | $10,000 | 2026 | General & Capital Purposes, unless noted |
| Compassionate Care ALS | Falmouth, MA | $10,000 | 2026 | General & Capital Purposes, unless noted |
| I AM ALS | Washington, DC | $5,000 | 2026 | General & Capital Purposes, unless noted |
| Live Like Lou Foundation | Oxford, OH | $5,000 | 2026 | General & Capital Purposes, unless noted |
| Emory University Hospital | Atlanta, GA | $580,000 | 2025 | ALS Research |
| Massachusetts General Hospital | Boston, MA | $500,000 | 2025 | ALS Research |
| R Packard Center for ALS Research | Baltimore, MD | $150,000 | 2025 | General & Capital Purposes, unless noted |
| UCL Queen Square Inst of Neurology | London | $120,000 | 2025 | ALS Research |
| Northeast ALS Consortium | Boston, MA | $100,000 | 2025 | General & Capital Purposes, unless noted |
| University of Michigan | Ann Arbor, MI | $85,000 | 2025 | ALS Research |
| Doctors Without Borders USA Inc | New York, NY | $85,000 | 2025 | General & Capital Purposes, unless noted |
| ALS Association | Arlington, MD | $75,000 | 2025 | ALS Research |
| Team Gleason Foundation | New Orleans, LA | $50,000 | 2025 | General & Capital Purposes, unless noted |
| Brain Cancer Research Institute | San Diego, CA | $50,000 | 2025 | General & Capital Purposes, unless noted |
| Hospital for Special Surgery | New York, NY | $40,000 | 2025 | General & Capital Purposes, unless noted |
| Cedar Sinai | Los Angeles, CA | $20,000 | 2025 | General & Capital Purposes, unless noted |
| ALS Therapy Development Institute | Watertown, MA | $20,000 | 2025 | General & Capital Purposes, unless noted |
| Hope Loves Company | Pennington, NJ | $15,000 | 2025 | General & Capital Purposes, unless noted |
| VCU ALS Research MCV Foundation | Richmond, VA | $10,000 | 2025 | General & Capital Purposes, unless noted |
| Everything ALS | Los Altos, CA | $10,000 | 2025 | General & Capital Purposes, unless noted |
| Target ALS Foundation | New York, NY | $10,000 | 2025 | General & Capital Purposes, unless noted |
| Hop On a Cure Foundation | Roswell, GA | $10,000 | 2025 | General & Capital Purposes, unless noted |
| ALS United New York | New York, NY | $10,000 | 2025 | General & Capital Purposes, unless noted |
| Project ALS | New York, NY | $10,000 | 2025 | General & Capital Purposes, unless noted |
| Les Turner Foundation | Skokie, IL | $10,000 | 2025 | General & Capital Purposes, unless noted |
| ALS One | Whitman, MA | $10,000 | 2025 | General & Capital Purposes, unless noted |
| Compassionate Care ALS | West Falmouth, MA | $10,000 | 2025 | General & Capital Purposes, unless noted |
| Answer ALS | New Orleans, LA | $10,000 | 2025 | General & Capital Purposes, unless noted |
| I AM ALS | Washington, DC | $5,000 | 2025 | General & Capital Purposes, unless noted |
| Live Like Lou Foundation | Oxford, OH | $5,000 | 2025 | General & Capital Purposes, unless noted |
| Emory University Hospital | Atlanta, GA | $510,000 | 2024 | ALS Research |
Emory University Hospital
$1,325,000ALS Research
Massachusetts General Hospital
$500,000ALS Research
John Hopkons University
$150,000General & Capital Purposes, unless noted
University of Michigan
$100,000ALS Research
ALS Association
$75,000ALS Research
Cedar Sinai
$30,000General & Capital Purposes, unless noted
Hope Loves Company
$15,000General & Capital Purposes, unless noted
Les Turner Foundation
$10,000General & Capital Purposes, unless noted
Target ALS Foundation
$10,000General & Capital Purposes, unless noted
Peter Cohen Foundation
$10,000General & Capital Purposes, unless noted
ALS United New York
$10,000General & Capital Purposes, unless noted
Compassionate Care ALS
$10,000General & Capital Purposes, unless noted
I AM ALS
$5,000General & Capital Purposes, unless noted
Emory University Hospital
$580,000ALS Research
Massachusetts General Hospital
$500,000ALS Research
R Packard Center for ALS Research
$150,000General & Capital Purposes, unless noted
UCL Queen Square Inst of Neurology
$120,000ALS Research
Northeast ALS Consortium
$100,000General & Capital Purposes, unless noted
University of Michigan
$85,000ALS Research
Doctors Without Borders USA Inc
$85,000General & Capital Purposes, unless noted
ALS Association
$75,000ALS Research
Brain Cancer Research Institute
$50,000General & Capital Purposes, unless noted
Cedar Sinai
$20,000General & Capital Purposes, unless noted
ALS Therapy Development Institute
$20,000General & Capital Purposes, unless noted
Hope Loves Company
$15,000General & Capital Purposes, unless noted
VCU ALS Research MCV Foundation
$10,000General & Capital Purposes, unless noted
Everything ALS
$10,000General & Capital Purposes, unless noted
Target ALS Foundation
$10,000General & Capital Purposes, unless noted
ALS United New York
$10,000General & Capital Purposes, unless noted
Project ALS
$10,000General & Capital Purposes, unless noted
Les Turner Foundation
$10,000General & Capital Purposes, unless noted
Compassionate Care ALS
$10,000General & Capital Purposes, unless noted
I AM ALS
$5,000General & Capital Purposes, unless noted
Emory University Hospital
$510,000ALS Research